Overview
Status
Active
Registry date
2012-09-10
Share capital
27,700.00 PLN
Registered address
ul. Budowlanych 65, 80-298 Gdańsk, Poland
Electronic delivery address
AE:PL-34808-29999-VTTSB-18
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 254 days for 2023).
- 2025not filed
- 202424/03/2026
- 202326/03/2025
- 202216/01/2024
- 202123/03/2023
- 202030/08/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Voivodeship · Pomorskie31,683 / 32,702
Top 97%
Country · Poland478,024 / 496,474
Top 96%
Results vs industry
Revenue
This companyUSD 2.51MedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -1.27kMedianUSD -1.27kAverageUSD -93.01k
Operating costs
This companyUSD 703.42MedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 7.50mMedianUSD 134.71kAverageUSD 3.04m
Industry
Authorized Representatives
Dawid Nidzworski age 42 – President of the Management Board
Manner of representation
Each member of the management board is authorized to independently represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 28 | $756.35 | 10.1083% | |
| 29 | $783.36 | 10.4693% | |
Sabina Elżbieta Nidzworska age 36 | 50 | $1,350.62 | 18.0505% |
Dawid Nidzworski age 42 | 100 | $2,701.24 | 36.1011% |
Kasjan Krzysztof Szemiako age 39 | 50 | $1,350.62 | 18.0505% |
Others | 20 | $540.25 | 7.2203% |
Dawid Nidzworski and Sabina Elżbieta Nidzworska hold a combined 54.2% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Geneme Molecular sp. z o.o. | 1,350.62 USD | 100% | ||
Uroscan sp. z o.o. | 1,350.62 USD | 50% | ||
Wdtech sp. z o.o. | 1,350.62 USD | 50% |
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 8, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,612$1,612 | Stowarzyszenie Wolna Przedsiębiorczość Oddział Terenowy w Gdańsku | |
| Jun 1, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Gdańsk |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Phage Consultants sp. z o.o. | $193,130.82 | phageconsultants.com | ||
| Pominno sp. z o.o. | $65,991.17 | pominno.pl | ||
| Recepton sp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Detoxed sp. z o.o. | $11,972.37 | detoxed.pl | ||
| Arthec S.A. | $10,911.16 | arthec.eu | ||
| MAP Your Dna Spólka z Ograniczoną Odpowiedzialnością sp. z o.o. | $7,283.38 | mapyourdna.eu | ||
| Innervision sp. z o.o. | $4.54 | innervision.pl | ||
| Immunotronics P.S.A. | $0.16 | immunotronics.net | ||
| Urteste S.A. | – | urteste.com | ||
| Astrofoods sp. z o.o. | – | astrofarms.space |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-05 | Address change (Ul. Kampinoska 25, 80-180, Gdańsk → Ul. Budowlanych 65, 80-298, Gdańsk) | |
| 2023-12-13 | Share capital increase (24,900.00 PLN → 27,700.00 PLN) | |
| 2023-05-19 | Share capital increase (20,000.00 PLN → 24,900.00 PLN) | |
| 2021-10-06 | Address change (Ul. Damroki 1/B6, 80-177, Gdańsk → Ul. Kampinoska 25, 80-180, Gdańsk) | |
| 2018-09-27 | Address change (Ul. Kładki 24, 80-822, Gdańsk → Ul. Damroki 1/B6, 80-177, Gdańsk) |
FAQ
The main business activity of Vttf focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on September 10, 2012.
The headquarters is located at: ul. Budowlanych 65, 80-298 Gdańsk.
The management board consists of: Dawid Nidzworski (President of the Management Board).
The share capital of the company is PLN 27,700 (approx. $7,482).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $3, representing a decrease of 100.0% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $1,269.
The largest operating cost category falls under external services. This category amounted to $703 in 2024, representing 100% of all operating expenses.
Last updated: 2026-03-24
